Last reviewed · How we verify

NCT05778422

Bupivacaine or Radiofrequency for Shoulder Pain

Completed NA Last updated 22 March 2023
What this trial tests

NA trial testing Suprascapular nerve block with bipuvacaine in Shoulder Pain in 40 participants. Completed in 1 January 2023.

Timeline
1 January 2021
Primary endpoint
1 January 2022
1 January 2023

Quick facts

Lead sponsorFederal University of São Paulo
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment40
Start date1 January 2021
Primary completion1 January 2022
Estimated completion1 January 2023
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of São Paulo

Who can join

Adults 18 to 90, any sex, with Shoulder Pain or Rotator Cuff Impingement Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparative study between pulsed radiofrequency in suprascapular nerve or bupivacaine block for chronic shoulder pain

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Shoulder Pain

Currently open trials in the same condition.

Other Federal University of São Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05778422.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing